HLN (Haleon) Prakiraan volume dodolan

Logo grafis Haleon plc (HLN)

The defensive nature of the Haleon plc (HLN) business ensures resilience during crises, although fierce competition for shelf space creates pressure. Projected sales revenues confirm the company's ability to maintain its position, and 17.96 becomes the new value of the indicator. This reinforces a strategy of global leadership through digitalization and expansion into emerging markets with premium products.

Prakiraan pendapatan perusahaan: Haleon Corp (HLN) kanggo 28.04.2023 - 17.11.2026

Ringkesan rincian data analitis Haleon Corp (HLN)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:Haleon HLN
Produk mawa merek Haleon Group

To objectively assess the investment attractiveness of Haleon plc, it is necessary to analyze the stability of its cash flows by filtering out one-time revenue spikes. This sales volume forecast measures the fundamental maturity of the operating model, where the absence of speculative anomalies confirms the effectiveness of brand portfolio optimization and the reduction of debt load, guaranteeing investors defensive capital stability without the risk of frozen funds.

Pesaing langsung

Prakiraan pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Prakiraan pendapatan perusahaan|AMRX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan perrigo.com|ALVO (Alvotech SA) - Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Prakiraan volume dodolan|ANIP: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Afrezza (MNKD)|Prakiraan volume dodolan amphastar.com (AMPH)|Prakiraan volume dodolan PCRX (pacira.com)|Pendapatan mangsa ngarep perusahaan SPRY|Theravance Biopharma Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Aquestive Therapeutics AQST|SCPH: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Prakiraan volume dodolan|SXTC (China SXT Pharmaceuticals, Inc.) - Prakiraan volume pendapatan perusahaan|Prakiraan pendapatan perusahaan eupraxiapharma.com (EPRX)|Prakiraan volume pendapatan perusahaan BHST|Prakiraan pendapatan perusahaan eXoZymes EXOZ|Pendapatan mangsa ngarep perusahaan ORMP|ENTX - Prakiraan pendapatan perusahaan|HYFT: Prakiraan pendapatan perusahaan|ABVC BioPharma, Inc (ABVC) - Prakiraan pendapatan perusahaan|Cumberland Pharma - Pendapatan mangsa ngarep perusahaan|QNTM (Quantum BioPharma Corp) - Prakiraan volume dodolan|FibroGen, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan TELO|Dodolan mangsa ngarep perusahaan Rani Therapeutics Holdings, Inc.|Prakiraan pendapatan perusahaan Synergy CHC Corp. SNYR|Prakiraan volume dodolan rallybio.com RLYB|Lexaria Bioscience Corp. - Prakiraan volume dodolan|PULM: Prakiraan pendapatan perusahaan|PTHL (ftzy.com.cn) - Volume dodolan mangsa ngarep perusahaan|APM: Prakiraan volume pendapatan perusahaan|LYRA (Lyra Therapeutics Inc) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan IBO (Impact BioMedical)|Volume dodolan mangsa ngarep perusahaan TNFA (TNF Pharmaceuticals)|Prakiraan volume dodolan cbdMD Corp (YCBD)|Prakiraan volume dodolan PRFX (PainReform)|Dodolan mangsa ngarep perusahaan Auris Medical (CYTO)|LIPO - Prakiraan pendapatan perusahaan|Optinose (OPTN) - Volume dodolan mangsa ngarep perusahaan|Pieris (PIRS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan PROC (Procaps Group S.A.)|Volume dodolan mangsa ngarep perusahaan PTPI|QLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan acelyrin.com (SLRN)|TFFP (TFF Pharma) - Pendapatan mangsa ngarep perusahaan